Purchase Order 36C24823P2500

Award Date 9/7/23
Potential Completion Date 9/29/23
Potential Value $15K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92614, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order valued at thirty-two thousand five hundred dollars to Edwards Lifesciences LLC for heart valve transcatheter aortic valve replacement (TAVR). Edwards Lifesciences LLC will perform the work as a division of its parent company, Edwards Lifesciences Corporation. The place of performance will be in Irvine, California over a one day period from November 8 through November 9, 2023. No set...
The Department of Veterans Affairs Veterans Health Administration awarded a $34,000.00 firm-fixed-price purchase order to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the delivery of transcatheter aortic valve replacement (TAVR) kits. The contract, which does not have a set-aside designation, has a completion date of May 20, 2024, and is part of the VA-VHA's efforts to provide specialized cardiovascular devices and services to support healthcare for veterans...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $34,000 purchase order to Edwards Lifesciences LLC for surgical implant transcatheter aortic valve replacement (TAVR). Edwards Lifesciences LLC will perform as the prime contractor, with its parent company Edwards Lifesciences Corporation. Performance will take place in Minneapolis, Minnesota over one day in late October 2023. The firm fixed price contract supports the VA's...
The Department of Veterans Affairs Veterans Health Administration awarded a $65,000 firm fixed price purchase order to Edwards Lifesciences LLC for Transcatheter Aortic Valve Replacement (TAVR) surgical implants. Edwards Lifesciences LLC will deliver the implants under the contract, which runs from July 26-27, 2023. The prime contractor is a division of Edwards Lifesciences Corporation. The place of performance will be in Minneapolis, Minnesota. No subcontractors or set aside designations were...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $34,000 purchase order to Edwards Lifesciences LLC for prosthetics surgical implant transcatheter aortic valve replacement (TAVR). Edwards Lifesciences LLC will perform the work as a division of its parent company, Edwards Lifesciences Corporation. The firm fixed price order is for a one day period of performance in Minneapolis, Minnesota from October 12-13, 2023. No set aside...
The Department of Veterans Affairs Veterans Health Administration awarded a $32,500 purchase order to Edwards Lifesciences LLC for prosthetics surgical implant transcatheter aortic valve replacement (TAVR) services. Edwards Lifesciences LLC will perform the work as a division of its parent company, Edwards Lifesciences Corporation. The firm fixed price order is for services to be delivered in Minneapolis, Minnesota between October 24-25, 2023 to the VA's Veterans Integrated Service Network 23....
This contract award to Edwards Lifesciences LLC, a limited liability company subsidiary of Edwards Lifesciences Corporation, provides transcatheter aortic valve replacement (TAVR) prosthetics and related services to the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The $113,000.00 firm fixed price purchase order has an ultimate completion date of September 2, 2024. The award is part of the VA-VHA's efforts to support cardiovascular care for veterans through...
The Department of Veterans Affairs Veterans Health Administration awarded a $34,000 purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) products and services. Edwards Lifesciences LLC, a division of Edwards Lifesciences Corporation, will deliver the TAVR solutions under a firm fixed price contract to support Veterans Integrated Service Network 23 programs in Minneapolis, Minnesota. No subcontractors or set aside designations were identified. The...
The Department of Veterans Affairs Veterans Health Administration awarded a $34,000 firm fixed price purchase order to Edwards Lifesciences LLC for the delivery of transcatheter aortic valve replacement (TAVR) surgical implants. Edwards Lifesciences LLC will perform as the prime contractor, with parent company Edwards Lifesciences Corporation. Delivery of the TAVR implants will occur between September 11-13, 2023 at the place of performance in Minneapolis, Minnesota. The award was made under...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Firm Fixed Price Purchase Order contract to Edwards Lifesciences LLC, a self-certified small disadvantaged business, for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products and related services. The contract, valued at $34,000.00, will be performed in Minneapolis, MN and is scheduled for completion by May 23, 2024. Edwards Lifesciences LLC, a limited liability company and subsidiary of Edwards...

The Department of Veterans Affairs Veterans Health Administration awarded a $15,000 firm fixed price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) valves. The prime contractor, Edwards Lifesciences LLC, is a division of Edwards Lifesciences Corporation and will deliver the valves under the contract, which runs from September 7-29, 2023. The place of performance is Edwards Lifesciences' facility in Irvine, California. The funding comes through VA-VHA Network 8 to support the Veterans Health Administration's provision of TAVR procedures, a minimally invasive alternative to open-heart surgery for treating aortic valve disease. No subcontractors or set aside designations were indicated in the award information.

Generated 12/18/23, 3:37 AM